RRAM
ABBV icon

River Road Asset Management’s AbbVie ABBV Stock Holding History

River Road Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.36M Sell
29,235
-2,126
-7% -$457K 0.08% 150
2026
Q1 		$6.82M Sell
31,361
-2,227
-7% -$494K 0.08% 152
2025
Q4 		$7.67M Sell
33,588
-8,863
-21% -$2.02M 0.08% 144
2025
Q3 		$9.83M Sell
42,451
-904
-2% -$184K 0.11% 138
2025
Q2 		$8.19M Buy
43,355
+674
+2% +$125K 0.1% 148
2025
Q1 		$8.94M Sell
42,681
-3,697
-8% -$719K 0.12% 130
2024
Q4 		$8.24M Sell
46,378
-8,211
-15% -$1.51M 0.11% 133
2024
Q3 		$10.8M Sell
54,589
-11,967
-18% -$2.23M 0.14% 119
2024
Q2 		$11.4M Sell
66,556
-2,574
-4% -$426K 0.16% 120
2024
Q1 		$12.6M Sell
69,130
-45,772
-40% -$7.89M 0.17% 121
2023
Q4 		$17.8M Sell
114,902
-2,747
-2% -$400K 0.25% 106
2023
Q3 		$17.5M Sell
117,649
-3,832
-3% -$563K 0.25% 107
2023
Q2 		$16.4M Sell
121,481
-4,934
-4% -$724K 0.23% 105
2023
Q1 		$20.1M Buy
126,415
+5,457
+5% +$834K 0.27% 102
2022
Q4 		$19.5M Sell
120,958
-33,181
-22% -$5.09M 0.27% 101
2022
Q3 		$20.7M Buy
154,139
+2,403
+2% +$345K 0.31% 97
2022
Q2 		$23.2M Sell
151,736
-32,193
-18% -$4.92M 0.33% 89
2022
Q1 		$29.8M Sell
183,929
-34,656
-16% -$5.03M 0.33% 84
2021
Q4 		$29.6M Sell
218,585
-20,715
-9% -$2.45M 0.32% 88
2021
Q3 		$25.8M Sell
239,300
-17,898
-7% -$2.05M 0.29% 90
2021
Q2 		$29M Sell
257,198
-34,895
-12% -$3.93M 0.31% 91
2021
Q1 		$31.6M Sell
292,093
-23,694
-8% -$2.53M 0.38% 71
2020
Q4 		$33.8M Sell
315,787
-95,004
-23% -$9.13M 0.48% 60
2020
Q3 		$36M Buy
410,791
+21,853
+6% +$2.06M 0.59% 51
2020
Q2 		$38.2M Sell
388,938
-52,762
-12% -$4.65M 0.66% 51
2020
Q1 		$33.7M Sell
441,700
-17,129
-4% -$1.46M 0.75% 48
2019
Q4 		$40.6M Sell
458,829
-9,576
-2% -$795K 0.64% 65
2019
Q3 		$35.5M Buy
+468,405
New +$32.1M 0.67% 61

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

River Road Asset Management's ABBV Position: Q2 2026 in Review

River Road Asset Management reduced its AbbVie (ABBV) stake by 6.8% in Q2 2026, selling an estimated $457K and leaving 29,235 shares worth $7.36M. The position accounts for 0.08% of the portfolio, ranked #150.

River Road Asset Management first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. The position peaked at $40.6M in Q4 2019. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • River Road Asset Management held 29,235 shares of AbbVie worth $7.36M as of Q2 2026.
  • River Road Asset Management sold 2,126 AbbVie shares in Q2 2026, an estimated $457K.
  • AbbVie made up 0.08% of River Road Asset Management's portfolio in Q2 2026, its #150 holding.
  • River Road Asset Management first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
  • River Road Asset Management's AbbVie position peaked at $40.6M in Q4 2019.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on River Road Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.